Skip to content
healthcare.dev
Get a free key

PACLITAXEL PROTEIN BOUND PARTICLES ALBUMIN BOUND

NDC 0517-4300, Paclitaxel, injection, powder, lyophilized, for suspension, from American Regent, Inc..

Product NDC
0517-4300
Status
Listed
Labeler
American Regent, Inc.
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA211875
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0517-4300 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PACLITAXEL100 mg/20mL

Pharmacologic classes

Microtubule Inhibition [PE]; Microtubule Inhibitor [EPC]

Package NDCNDC-11Package
0517-4300-01005174300011 VIAL in 1 CARTON (0517-4300-01) / 20 mL in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/f06d1bb3-83f1-4d84-8004-4c6681ad8a5a

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=0517-4300

Use it

Look up 0517-4300 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0517-4300 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0517-4300. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.